- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.3: 2 residues within 4Å:- Chain A: Q.15, N.23
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.15
NAG.4: 1 residues within 4Å:- Chain A: N.154
No protein-ligand interaction detected (PLIP)NAG.5: 1 residues within 4Å:- Chain A: N.286
No protein-ligand interaction detected (PLIP)NAG.16: 2 residues within 4Å:- Chain B: Q.15, N.23
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Q.15
NAG.17: 1 residues within 4Å:- Chain B: N.154
No protein-ligand interaction detected (PLIP)NAG.18: 1 residues within 4Å:- Chain B: N.286
No protein-ligand interaction detected (PLIP)NAG.29: 2 residues within 4Å:- Chain C: Q.15, N.23
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Q.15
NAG.30: 1 residues within 4Å:- Chain C: N.154
No protein-ligand interaction detected (PLIP)NAG.31: 1 residues within 4Å:- Chain C: N.286
No protein-ligand interaction detected (PLIP)- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.6: 9 residues within 4Å:- Chain A: V.16, D.17, R.310, L.311, V.312, E.427, V.430, L.431, N.434
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:D.17, A:D.17, A:V.312, A:E.427, A:E.427, A:N.434
PEG.7: 6 residues within 4Å:- Chain A: C.4, W.344, H.355, Y.364, N.465, C.467
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:H.355, A:Y.364
PEG.8: 4 residues within 4Å:- Chain A: D.88, N.94, F.95, Y.98
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:N.94, A:F.95
- Hydrogen bonds: A:D.88
PEG.9: 4 residues within 4Å:- Chain A: H.28, V.348, G.350, W.351
No protein-ligand interaction detected (PLIP)PEG.19: 9 residues within 4Å:- Chain B: V.16, D.17, R.310, L.311, V.312, E.427, V.430, L.431, N.434
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:D.17, B:D.17, B:V.312, B:E.427, B:E.427, B:N.434
PEG.20: 6 residues within 4Å:- Chain B: C.4, W.344, H.355, Y.364, N.465, C.467
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:H.355, B:Y.364
PEG.21: 4 residues within 4Å:- Chain B: D.88, N.94, F.95, Y.98
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:N.94, B:F.95
- Hydrogen bonds: B:D.88
PEG.22: 4 residues within 4Å:- Chain B: H.28, V.348, G.350, W.351
No protein-ligand interaction detected (PLIP)PEG.32: 9 residues within 4Å:- Chain C: V.16, D.17, R.310, L.311, V.312, E.427, V.430, L.431, N.434
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:D.17, C:D.17, C:V.312, C:E.427, C:E.427, C:N.434
PEG.33: 6 residues within 4Å:- Chain C: C.4, W.344, H.355, Y.364, N.465, C.467
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:H.355, C:Y.364
PEG.34: 4 residues within 4Å:- Chain C: D.88, N.94, F.95, Y.98
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:N.94, C:F.95
- Hydrogen bonds: C:D.88
PEG.35: 4 residues within 4Å:- Chain C: H.28, V.348, G.350, W.351
No protein-ligand interaction detected (PLIP)- 12 x MG: MAGNESIUM ION(Non-covalent)
MG.10: 7 residues within 4Å:- Chain A: Y.7, H.8, A.9, L.317, R.318, N.319, S.320
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:H.8, A:R.318, A:S.320
MG.11: 6 residues within 4Å:- Chain A: G.6, Y.7, I.340, G.342, G.343, W.344
1 PLIP interactions:1 interactions with chain A- Metal complexes: A:G.342
MG.12: 6 residues within 4Å:- Chain A: Y.449, L.463, G.464, N.465, G.466, C.467
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:Y.449, A:C.467
MG.13: 6 residues within 4Å:- Chain A: L.52, R.53, C.55, E.81, K.82, P.85
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:L.52, A:R.53, A:C.55
MG.23: 7 residues within 4Å:- Chain B: Y.7, H.8, A.9, L.317, R.318, N.319, S.320
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:H.8, B:R.318, B:S.320
MG.24: 6 residues within 4Å:- Chain B: G.6, Y.7, I.340, G.342, G.343, W.344
1 PLIP interactions:1 interactions with chain B- Metal complexes: B:G.342
MG.25: 6 residues within 4Å:- Chain B: Y.449, L.463, G.464, N.465, G.466, C.467
2 PLIP interactions:2 interactions with chain B- Metal complexes: B:Y.449, B:C.467
MG.26: 6 residues within 4Å:- Chain B: L.52, R.53, C.55, E.81, K.82, P.85
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:L.52, B:R.53, B:C.55
MG.36: 7 residues within 4Å:- Chain C: Y.7, H.8, A.9, L.317, R.318, N.319, S.320
3 PLIP interactions:3 interactions with chain C- Metal complexes: C:H.8, C:R.318, C:S.320
MG.37: 6 residues within 4Å:- Chain C: G.6, Y.7, I.340, G.342, G.343, W.344
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:G.342
MG.38: 6 residues within 4Å:- Chain C: Y.449, L.463, G.464, N.465, G.466, C.467
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:Y.449, C:C.467
MG.39: 6 residues within 4Å:- Chain C: L.52, R.53, C.55, E.81, K.82, P.85
3 PLIP interactions:3 interactions with chain C- Metal complexes: C:L.52, C:R.53, C:C.55
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bar-Peled, Y. et al., Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine. Vaccine (2019)
- Release Date
- 2019-09-18
- Peptides
- Hemagglutinin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 12 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 12 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bar-Peled, Y. et al., Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine. Vaccine (2019)
- Release Date
- 2019-09-18
- Peptides
- Hemagglutinin: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A